Skip to content

The real world study of BieJiaJianWan on hepatic fibrosis

The real world study of BieJiaJianWan on hepatic fibrosis

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPN-15007013
Enrollment
Unknown
Registered
2015-08-20
Start date
2015-08-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic fibrosis

Interventions

Case series:Oral biejiajianwan

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients that are suitable for the treatment of biejiajianwan can be included. The ones that can take medication for more than 3 months can be included as object of statistics.

Exclusion criteria

Exclusion criteria: 1. In the treatment of women in pregnancy,the patients with ascites or other severe complications; 2. Patients with sereve disease of the heart,liver or the kindy,with mental disorder or dysgnosia; 3. Patients who are involved in the research of other medical projects within 2 months; 3. Termination criteria: (1) Patients that have declared willing to leave the study, due to severe side effects and during the study; (2) Patients that the doctor deems as inappropriate for further treatment.

Design outcomes

Primary

MeasureTime frame
hepatic fibrosis;

Countries

China

Contacts

Public ContactLiu Li
liulisipi@foxmail.com+86 15921628956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026